Dual impacts of serine/glycine-free diet in enhancing antitumor immunity and promoting evasion via PD-L1 lactylation
The effect of the serine/glycine-free diet (-SG diet) on colorectal cancer (CRC) remains unclear; meanwhile, programmed death-1 (PD-1) inhibitors are less effective for most CRC patients. Here, we demonstrate that the -SG diet inhibits CRC growth and promotes the accumulation of cytotoxic T cells to enhance antitumor immunity. Additionally, we also identified the lactylation of programmed death-ligand 1 (PD-L1) in tumor cells as a mechanism of immune evasion during cytotoxic T cell-mediated antitumor responses, and blocking the PD-1/PD-L1 signaling pathway is able to rejuvenate the function of CD8+ T cells recruited by the -SG diet, indicating the potential of combining the -SG diet with immunotherapy. We conducted a single-arm, phase I study (ChiCTR2300067929). The primary outcome suggests that the -SG diet is feasible and safe for regulating systemic immunity. Secondary outcomes include patient tolerability and potential antitumor effects. Collectively, our findings highlight the promising therapeutic potential of the -SG diet for treating solid tumors.
Authors
- Nan Lin (ORCID: https://orcid.org/0000-0003-0083-6804)
- Xiaoyue Li (ORCID: https://orcid.org/0000-0003-2838-2146)
- Changtong He (ORCID: https://orcid.org/0000-0002-0558-3343)
- Xiao Liang (ORCID: https://orcid.org/0000-0003-0330-7027)
- Xuelei Ma (ORCID: https://orcid.org/0000-0002-9148-5001)
- Zhiwen Long (ORCID: https://orcid.org/0000-0002-6516-3156)
- Yuhao Wei (ORCID: https://orcid.org/0000-0001-9007-3200)
- Yun Hong
- Xiang Yu (ORCID: https://orcid.org/0000-0001-6541-1562)
- Jiayi Xu (ORCID: https://orcid.org/0000-0002-4830-7648)
- Hubing Shi (ORCID: https://orcid.org/0000-0002-2926-3440)
- Huan Tong (ORCID: https://orcid.org/0000-0002-2874-5675)
- Liqiang Feng (ORCID: https://orcid.org/0000-0001-6811-2074)
- Aiping Zheng (ORCID: https://orcid.org/0000-0001-8870-0914)
- Jun Yin (ORCID: https://orcid.org/0009-0008-5428-9969)
- Tao Zhang (ORCID: https://orcid.org/0000-0002-4957-9848)
- Yu Zhang (ORCID: https://orcid.org/0000-0003-0220-8203)
- Xinggang Yang (ORCID: https://orcid.org/0000-0002-8319-5151)
- Juan Huang (ORCID: https://orcid.org/0000-0002-5330-8338)
- Linlin Song (ORCID: https://orcid.org/0000-0001-6398-6725)
- Qiang Luo (ORCID: https://orcid.org/0000-0001-5682-5536)
- Xiaomeng Yin (ORCID: https://orcid.org/0000-0003-0882-6600)
- Zhen Lei (ORCID: https://orcid.org/0000-0002-9589-6326)
- Yuting Jiang (ORCID: https://orcid.org/0009-0007-4222-9056)
- Yueyi Li (ORCID: https://orcid.org/0000-0003-3384-0674)
- Guangqi Li (ORCID: https://orcid.org/0000-0003-3002-4778)
- Yunuo Zhao (ORCID: https://orcid.org/0000-0002-5818-9278)
- Renwei Li (ORCID: https://orcid.org/0009-0004-5828-5069)
- Yi Wan (ORCID: https://orcid.org/0000-0002-4125-8396)
- Qianlong Kang
- Xiaofan Jing
- Z. X. Jiang
- Keqin Tan
Institutions
- University of Electronic Science and Technology of China (CN)
- Sichuan University (CN)
- West China Hospital of Sichuan University (CN)
- The Recovery Center (US)
- Sichuan Academy of Medical Sciences & Sichuan Provincial People's Hospital (CN)
- Sichuan Cancer Hospital (CN)
- Sichuan Provincial Hospital of Traditional Chinese Medicine (CN)
Publication Details
- Journal
- Cell Metabolism
- Published
- 2024-11-21
- DOI
- https://doi.org/10.1016/j.cmet.2024.10.019
- Citations
- 107
- Primary Topic
- Cancer, Stress, Anesthesia, and Immune Response
- Type
- article
- Field-Weighted Citation Impact
- 40.87